Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

BACKGROUND: Viral diversity seems to predict treatment outcomes in certain viral infections. The aim of this study was to evaluate the association between baseline intra-patient viral diversity and hepatitis B surface antigen (HBsAg) decline following PEGylated interferon-alpha (Peg-IFN-α) therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hu, Zhang, Li, Ren, Hong, Hu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939877/
https://www.ncbi.nlm.nih.gov/pubmed/29765238
http://dx.doi.org/10.2147/IDR.S163765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939877/
https://www.ncbi.nlm.nih.gov/pubmed/29765238
http://dx.doi.org/10.2147/IDR.S163765

Ejemplares similares